PF icon
Feature Partner

Psilera

Quick Overview of Psilera

Company Status
Public
Private
Non-Profit
Parent Company
CSE Ticker
FSE TICKER
OTC Ticker
TSX TICKER
TSX Venture TICKER
NEO TICKER
NASDAQ TICKER
NYSE TICKER

Company Summary

About

Psilera is a leading biotechnology company developing proprietary neuromodulators based on traditionally psychoactive compounds targeting mental health disorders. Psilera's next-generation data platform is being used to identify lead compounds with modified psychedelic and therapeutic effects in mood, cognitive, and substance use disorders. New formulations tailoring the therapeutic effects of DMT will improve treatment scalability and patient compliance, further expanding addressable markets. Psilera leverages a world-class scientific and pharmaceutical executive team to repurpose psychoactive natural products into effective and accessible patient-centric treatments.